Preparation and in vitro evaluation of amphiphilic paclitaxel small molecule prodrugs and enhancement of oral absorption.

[1]  Chenyu Zhang,et al.  Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment. , 2020, European journal of medicinal chemistry.

[2]  W. Xu,et al.  Redox- and MMP-2-sensitive drug delivery nanoparticles based on gelatin and albumin for tumor targeted delivery of paclitaxel. , 2020, Materials science & engineering. C, Materials for biological applications.

[3]  P. Zhang,et al.  Drug-Bearing Peptide-based Nanospheres for the Inhibition of Metastasis and Growth of Cancer. , 2020, Molecular pharmaceutics.

[4]  Zhuxian Zhou,et al.  Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[5]  J. Sun,et al.  Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB0,+ for efficient tumor therapy. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Yuanhui Ji,et al.  Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[7]  J. Sun,et al.  Bioactivatable pseudo-tripeptidization of cyclic dipeptides to increase the affinity toward oligopeptide transporter 1 for enhanced oral absorption: an application to cyclo(L-Hyp-L-Ser) (JBP485). , 2019, Journal of medicinal chemistry.

[8]  Zhihua Gan,et al.  Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy , 2019, Nature Nanotechnology.

[9]  Shweta Sharma,et al.  Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression. , 2019, Biomaterials science.

[10]  H. Ren,et al.  Role of Liposome Size, Surface Charge, and PEGylation on Rheumatoid Arthritis Targeting Therapy. , 2019, ACS applied materials & interfaces.

[11]  A. Khan,et al.  Current development in the formulations of non‐injection administration of paclitaxel , 2018, International journal of pharmaceutics.

[12]  Dongyang Zhao,et al.  Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes. , 2018, International journal of pharmaceutics.

[13]  G. Ma,et al.  Positively Charged Polyprodrug Amphiphiles with Enhanced Drug Loading and Reactive Oxygen Species-Responsive Release Ability for Traceable Synergistic Therapy. , 2018, Journal of the American Chemical Society.

[14]  Haotian Zhang,et al.  Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer‐lipid hybrid nanoparticles , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Yaping Li,et al.  Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance , 2018, Theranostics.

[16]  Yanran Wang,et al.  Quantification of Paclitaxel and Polyaspartate Paclitaxel Conjugate in Beagle Plasma: Application to a Pharmacokinetic Study. , 2017, Journal of chromatographic science.

[17]  Feng Jiang,et al.  Prodrug Strategies for Paclitaxel , 2016, International journal of molecular sciences.

[18]  D. Chiappetta,et al.  Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. , 2016, Colloids and surfaces. B, Biointerfaces.

[19]  Ke Zhang,et al.  Light-triggered, self-immolative nucleic Acid-drug nanostructures. , 2015, Journal of the American Chemical Society.

[20]  J. Ji,et al.  Doxorubicin conjugated phospholipid prodrugs as smart nanomedicine platforms for cancer therapy. , 2015, Journal of materials chemistry. B.

[21]  Yu Cao,et al.  An immunosuppressive antibody-drug conjugate. , 2015, Journal of the American Chemical Society.

[22]  Yaping Li,et al.  A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer. , 2014, International journal of pharmaceutics.

[23]  Grigory Tikhomirov,et al.  Bioorthogonal Cyclization-Mediated In Situ Self-Assembly of Small Molecule Probes for Imaging Caspase Activity in vivo , 2014, Nature chemistry.

[24]  Zhilong Hu,et al.  Synthesis and thermoreversible gelation of coil-helical polyethylene-block-poly(γ-benzyl-l-glutamate) diblock copolymer , 2013 .

[25]  Jianping Zhou,et al.  Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  He Lian,et al.  Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. , 2011, International journal of pharmaceutics.

[27]  Q. Ping,et al.  The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. , 2011, Biomaterials.

[28]  L. Mayer,et al.  Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations , 2011, Chemotherapy research and practice.

[29]  Russell J Mumper,et al.  Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. , 2009, Cancer research.

[30]  Yoshio Hayashi,et al.  Paclitaxel prodrugs: toward smarter delivery of anticancer agents. , 2006, Journal of medicinal chemistry.

[31]  M. Skwarczynski,et al.  A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel. , 2003, Journal of medicinal chemistry.

[32]  A. Khanna,et al.  Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers. , 2015, Bioorganic & medicinal chemistry letters.

[33]  Yongbing Sun,et al.  Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine. , 2009, Molecular pharmaceutics.